In patients with severe COVID‐19, the levels of many pro‐inflammatory factors (eg, IL‐6, IL‐2, and tumor necrosis factor‐alpha) were significantly elevated, and levels of regulatory T cells decreased significantly.7 The gene discussed is IL2; the disease is COVID-19.